| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06669013 | Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas | Bone Sarcoma | Recruiting |
| NCT07258680 | BrEto-TCL - Defining the Role of Brentuximab and Etoposide for Optimizing First-line… | Peripheral T-cell Lymphoma | Enrolling by Invitation |
| Phase 2 | |||
| NCT06229340 | Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory… | RAS Mutation | Recruiting |
| NCT06418789 | High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors | Germ Cell Tumor | Recruiting |
| Not specified | |||
| NCT04330456 | Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative… | Soft Tissue Sarcoma Adult | Recruiting |
| NCT04293796 | Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete… | Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB | Recruiting |
| NCT05539677 | Biobank and Register of Patients With Agresive Tumors for Translational and Analytical… | Malignant Solid Tumors | Recruiting |
| NCT07579286 | Refusal of Sentinel Lymph Node Biopsy in Patients With Luminal A Subtype Early Breast… | Early Breast Cancer | Recruiting |
| NCT06043947 | Survival Monitoring in Russian Cancer Registries | Melanoma | Active, Not Recruiting |